COMPANION DIAGNOSTICS -Pharmacogenetics

TECNALIA, experts in Pharmaceutical Development, Scale-up & Pilot Batches Manufacturing, Clinical Trials and Contract Manufacturing.

The activities of TECNALIA´s Genetic and Molecular Biology Grop on the Biomedical sector aim to bring P4 Medicine (Predictive, Preventive, Personalized and Participatory) to patients and professionals.
In this regard, the Genetics and Molecular Biology Laboratory devotes a significant portion of its resources to develop assays and in vitro tests for disease diagnosis, prognosis and prediction of drug response (Companion Diagnostics).

Personalized /
• Proper treatment at the right dose.
• To the right patient / disease.
• At the right time.
• For the right outcome.

Predictive /
• Prediction of response to therapy.
• Efficiency vs toxicity.

Preventive /
Evaluate risk and predisposition to
certain diseases.
It allows the adoption of preventive measures to delay, or even eliminate, the occurrence of the disease or early diagnosis.

Participatory /
To involve the patient in the management of his/her disease: treatment options, prevention strategies, monitoring of the disease and risks.